Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Blood|September 7, 2014
JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosisXiaoli Wang, Fei Ye, Joseph Tripodi, et al.
Acta Haematologica|June 12, 2025
Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to TherapyDaniel I Nathan, Ronald Hoffman, Daiva Ahire, et al.
Leukemia Research|December 23, 2014
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosisSrdan Verstovsek, Ronald Hoffman, John Mascarenhas, et al.
Blood|August 9, 2003
Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell diseaseYogen Saunthararajah, Cheryl A Hillery, Don Lavelle, et al.
Blood|February 16, 2006
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting functionJavaneh Abbasian, Dolores Mahmud, Nadim Mahmud, et al.
British Journal of Haematology|March 8, 2008
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantationStefan O Ciurea, Barry Sadegi, Andrew Wilbur, et al.
Leukemia|December 23, 2024
HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosisShivani Handa, Christoph Schaniel, Joseph Tripodi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2016
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase MyelofibrosisAlla Keyzner, Sarah Han, Samantha Shapiro, et al.
Blood|February 12, 2005
Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteasesMingjiang Xu, Edward Bruno, Joseph Chao, et al.
Blood|May 30, 2015
Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cellsMin Lu, Lijuan Xia, Yen-Chun Liu, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Blood|September 7, 2014
JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosisXiaoli Wang, Fei Ye, Joseph Tripodi, et al.
Acta Haematologica|June 12, 2025
Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to TherapyDaniel I Nathan, Ronald Hoffman, Daiva Ahire, et al.
Leukemia Research|December 23, 2014
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosisSrdan Verstovsek, Ronald Hoffman, John Mascarenhas, et al.
Blood|August 9, 2003
Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell diseaseYogen Saunthararajah, Cheryl A Hillery, Don Lavelle, et al.
Blood|February 16, 2006
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting functionJavaneh Abbasian, Dolores Mahmud, Nadim Mahmud, et al.
British Journal of Haematology|March 8, 2008
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantationStefan O Ciurea, Barry Sadegi, Andrew Wilbur, et al.
Leukemia|December 23, 2024
HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosisShivani Handa, Christoph Schaniel, Joseph Tripodi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2016
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase MyelofibrosisAlla Keyzner, Sarah Han, Samantha Shapiro, et al.
Blood|February 12, 2005
Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteasesMingjiang Xu, Edward Bruno, Joseph Chao, et al.
Blood|May 30, 2015
Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cellsMin Lu, Lijuan Xia, Yen-Chun Liu, et al.
Pageof 21